Abstract
We experienced two cases of unrelated Japanese children with bacille Calmette–Guérin (BCG) multiple osteomyelitis with partial interferon (IFN)-γ receptor 1 (IFNGR1) deficiency. Heterozygous small deletions with frame shift (811 del4 and 818 del4) were detected, which were consistent with the diagnosis of partial dominant IFNGR1 deficiency. Case 1: a 2-year-old boy visited us because of limb and neck pain. He had been vaccinated with BCG at 17 months of age. Multiple destructive lesions were observed in the skull, ribs, femur, and vertebral bones. Mycobacterium bovis (BCG Tokyo 172 strain by RFLP technique) was detected in the bone specimen. The BCG multiple osteomyelitis was treated successfully without recurrence. Case 2: an 18-month-old girl developed multiple osteomyelitis 9 months after BCG inoculation. Radiologic images showed multiple osteolytic lesions in the skull, ribs, femur, and vertebrae. M. bovis (BCG Tokyo 172 strain) was detected in the cultures from a bone biopsy. Her clinical course showed recurrent osteomyelitis and lymphadenitis with no pulmonary involvement. The effects of high-dose antimycobacterial drugs and IFN-γ administration were transient, and complete remission has since been achieved by combination antimycobacterial therapy, including levofloxacin. Partial dominant IFNGR1 deficiency is a rare disorder, but it should be considered when a patient presents with multiple osteomyelitis after BCG vaccination. The cases that are resistant to conventional regimens require additional second-line antituberculous drugs, such as levofloxacin.
References
Dupuis S, Döffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, et al. Human interferon-γ-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178:129–37.
Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18:347–61.
Sasaki Y, Nomura A, Kusuhara K, Takada H, Ahmed S, Obinata K, et al. Genetic basis of patients with Bacille Calmette–Guérin (BCG) osteomyelitis in Japan: identification of dominant partial interferon-γ receptor 1 deficiency as a predominant type. J Infect Dis. 2002;185:706–9.
Milstein JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine efficacy and safety. Bull WHO. 1990;68:93–108.
Toida I, Nakata S. Severe adverse reactions after vaccination with Japanese BCG vaccine: a review. Kekkaku. 2007;82:809–24 (in Japanese).
Hoshina T, Takada H, Sasaki-Mihara Y, Kusuhara K, Ohshima K, Okada S, Kobayashi M, Ohara O, Hara T. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial disease in Japan. J Clin Immunol. 2011;31:309–14.
Lee W-I, Huang J-L, Lin T-Y, Hsueh C, Wong AM, Hsieh M-Y, et al. Chinese patients with defective IL-12/23-interferon-γ circuit in Taiwan: partial dominant interferon-γ receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor γ1 mutation as pneumatocele. J Clin Immunol. 2009;29:238–45.
Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Barreto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364:2113–21.
Remus N, Reichenbach J, Picard C, Rietschel C, Wood P, Lammas D, et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr Res. 2001;50:8–13.
Fennelly GJ. Mycobacterium bovis versus Mycobacterium tuberculosis as a cause of acute cervical lymphadenitis without pulmonary diseases. Pediatr Infect Dis J. 2004;23:590–1.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Obinata, K., Lee, T., Niizuma, T. et al. Two cases of partial dominant interferon-γ receptor 1 deficiency that presented with different clinical courses of bacille Calmette–Guérin multiple osteomyelitis. J Infect Chemother 19, 757–760 (2013). https://doi.org/10.1007/s10156-012-0493-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-012-0493-5